NR 565 Pharmacotherapeutics for Primary Care Week 1 Quiz, Chamberlain University, 2026/2027 | Verified Questions and Detailed Answers

1|Page


NR 565 Pharmacotherapeutics for Primary Care Week 1 Quiz,
Chamberlain University, 2026/2027 | Verified Questions and
Detailed Answers

OVERVIEW DESCRIPTION
This comprehensive set of multiple-choice questions is designed for the NR 565 Week
1 Quiz, which evaluates foundational principles of advanced pharmacotherapeutics
applied to primary care. The assessment covers core pharmacokinetic and
pharmacodynamic concepts, including ADME processes, half-life, therapeutic index,
and the cytochrome P450 system, along with safe prescribing considerations for
special populations such as geriatric and pediatric patients. Questions also address
key regulatory and practice issues, including FDA boxed warnings, pharmacogenomics,
the Beers Criteria, and APRN prescriptive authority and scope of practice.

QUESTION 1
Which organ is primarily responsible for drug metabolism?

A) Kidneys
B) Liver

C) Lungs
D) Small intestine

CORRECT ANSWER: B) Liver
EXPERT RATIONALE: The liver contains cytochrome P450 enzymes that perform Phase I

metabolism, making it the primary site of biotransformation. While the kidneys excrete
metabolites, they are not the main metabolic organ.


QUESTION 2
A drug with a narrow therapeutic index requires:

A) Once-daily dosing regardless of half-life
B) No monitoring of blood levels
C) Regular monitoring of peak and trough levels

,2|Page


D) Over-the-counter availability

CORRECT ANSWER: C) Regular monitoring of peak and trough levels
EXPERT RATIONALE: Narrow therapeutic index drugs have a small margin between

effective and toxic doses. Monitoring peak and trough levels ensures therapeutic
concentrations are achieved without toxicity.


QUESTION 3
Which term describes the movement of a drug from the bloodstream into tissues?

A) Absorption
B) Distribution

C) Metabolism
D) Excretion

CORRECT ANSWER: B) Distribution
EXPERT RATIONALE: Distribution is the process by which a drug leaves the bloodstream

and enters the interstitial and cellular tissues. Factors like protein binding and blood
flow influence this step.


QUESTION 4
A patient with end-stage renal disease is likely to experience what alteration in
pharmacokinetics?
A) Increased hepatic metabolism

B) Decreased drug excretion
C) Enhanced drug absorption

D) Reduced volume of distribution
CORRECT ANSWER: B) Decreased drug excretion

EXPERT RATIONALE: The kidneys are the primary route of excretion for most drugs and
their metabolites. Renal impairment prolongs half-life and increases the risk of drug
accumulation and toxicity.

, 3|Page


QUESTION 5

What does the term "half-life" of a drug indicate?
A) Time to reach maximum concentration

B) Time for the drug to be completely eliminated
C) Time required for the plasma concentration to decrease by 50%

D) Duration of therapeutic effect
CORRECT ANSWER: C) Time required for the plasma concentration to decrease by 50%

EXPERT RATIONALE: Half-life is a pharmacokinetic parameter that determines dosing
frequency. Approximately 4-5 half-lives are needed to achieve steady-state or eliminate

the drug.

QUESTION 6

Which of the following is a Phase II metabolic reaction?
A) Oxidation

B) Reduction
C) Hydrolysis

D) Glucuronidation
CORRECT ANSWER: D) Glucuronidation

EXPERT RATIONALE: Phase II reactions involve conjugation, such as glucuronidation,
sulfation, or acetylation, to make drugs more water-soluble for excretion. Phase I

reactions include oxidation, reduction, and hydrolysis.

QUESTION 7

The Beers Criteria is specifically used to guide prescribing in which population?
A) Neonates

B) Pregnant women
C) Older adults
D) Adolescents